ArticleClinical and translational medicine2022

Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.

Anna Reustle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.